ALDX FY 2015 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ALDXAldeyra Therapeutics, Inc.

$290M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$18,778

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$28M

Total Liabilities

$3M

Stockholders' Equity

$25M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$18,778	$0	—
Operating Income	-$12M	-$7M	-64.9%
Net Income	-$12M	-$5M	-133.1%